C entral tolerance in the B lineage is maintained by several distinct mechanisms. These include deletion, which purges from the repertoire B cells with highly self-reactive Ig receptors (1, 2), and induction of clonal anergy, which renders B cells nonresponsive to B cell receptor (BCR) 3 crosslinking (3). In addition, it is now clear that central receptor editing, particularly at light chain loci, maintains tolerance by modifying the Ag receptor specificity of self-reactive cells through the initiation of new Ig light chain rearrangements (4, 5). The fate of individual autoreactive B cells depends on the strength of signaling through the BCR and the developmental stage at which BCR cross-linking by self-Ag occurs (6 -9). For the most part, deletion, editing, and anergy have been considered independent mechanisms working to maintain B cell tolerance.
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Our laboratory recently showed that transgenic (Tg) overexpression of the anti-apoptotic protein Bcl-x L allowed self-reactive bone marrow (BM) B cells to escape central deletion in mice Tg for both a BCR recognizing hen egg lysozyme (HEL-Ig) and membranebound HEL (mHEL) (10) . In the course of these studies, we noted that recombination-activating gene (Rag)-2 was strongly induced in BM B cells of HEL-Ig/mHEL animals in the absence of new light chain rearrangements. Since these mice showed nearly complete central deletion of B cells, this suggested an abortive attempt at receptor editing in response to extremely high levels of BCR cross-linking by membrane-bound self-Ag. We also found that bcl-x L allowed HEL-Ig B cells to escape deletion in the mHEL environment. In the periphery, these "escaped" B cells were profoundly anergic in both in vitro and in vivo assays, and showed evidence of extensive receptor editing with up-regulated Rag-1 and Rag-2 mRNA expression and new endogenous rearrangements (10) .
Based on these results, we were interested in further exploring the relationship between anergy induction and receptor editing. In anergic HEL-Ig/soluble HEL (sHEL) double Tg mice, the lysozyme self-Ag is present in the fluid phase and the level of Ig receptor cross-linking is significantly lower than in HEL-Ig/mHEL mice (6) . The data presented here indicate that anergic B cells in HEL-Ig/sHEL mice indeed exhibit evidence of receptor editing, as determined by the detection of endogenous V-J1 light chain rearrangements. In addition, new endogenous V-J1 rearrangements could be induced in an IL-7-driven in vitro BM culture system following incubation of HEL-Ig B cell cultures with exogenous sHEL or several lysozyme variants with lower affinity for the HEL-Ig BCR. These data have interesting implications for our understanding of the nature of B cell tolerance induction in the BM.
Materials and Methods

Mice
MD4 HEL-Ig and ML5 sHEL Tg mice (3) were kindly provided by C. Goodnow (Australian National University, Canberra, Australia). Mice were genotyped by PCR of genomic DNA obtained from tail biopsy at the time of weaning. All animals were maintained in specific pathogen-free isolation at the University of Minnesota animal facility. Mice used for experiments were generally 4 -8 wk of age.
IL-7 BM cultures
BM cells were flushed from tibiae and fibulae of HEL-Ig mice. Cell suspensions were depleted of RBC by lysis with 0.15 M NH 4 Cl, 1 mM KHCO 3 , and 0.1 mM Na 2 EDTA and cultured in complete media (45% Enriched Eagle's Medium (Biofluids, Rockville, MD), 45% RPM1 1640 (Mediatech, Washington, DC), 10% heat-inactivated FCS, L-glutamine, penicillin, and streptomycin) at a concentration of 2 ϫ 10 6 cells/ml. Cultures were performed in the presence of recombinant mouse IL-7 (R&D Systems, Minneapolis, MN) at 16 ng/ml for 5 days at 37°C in 5% CO 2 (first-stage culture). In some experiments, freshly prepared HEL (Sigma, St. Louis, MO) (sterile filtered in complete media) was added at a concentration of 200 ng/ml, unless otherwise noted. For second-stage cultures, cells were harvested at day 5, washed extensively with PBS, and then recultured in complete media at a concentration of 10 6 cells/ml without IL-7 and in the presence or absence of HEL. Cells were then harvested after 2-day cultures for further analysis. To measure proliferation, quadruplicate samples (1 ϫ 10 5 cells in 200 l media in 96-well flat-bottom plates) were cultured with IL-7 and HEL for 5 days. Cell counts were performed using trypan blue exclusion at day 4, and parallel cultures were pulsed for 16 h with 1 Ci of [
3 H]thymidine before harvest and scintillation counting.
Cells from first-stage cultures were also harvested and washed, then recultured in complete media in the absence or presence of 10 ng/ml IL-4 (R&D Systems), 200 ng/ml HEL, or 10 g/ml F(abЈ) 2 goat anti-mouse IgM Abs (Jackson ImmunoResearch, West Grove, PA). [ 3 H]Thymidine incorporation was measured for the last 16 h of a 2-day culture. Duck egg lysozyme was custom produced by Rockland Immunochemical (Gilbertsville, PA) and was Ͼ98% pure by SDS-PAGE. J558 cells engineered to secrete sitedirected HEL mutants were kindly provided by F. Battista and M. Neuberger (London, U.K.) (15) . Cells were grown in complete RPMI 1640 media, and recombinant proteins were purified from culture supernatants by ion exchange chromatography on CM-52 cellulose as described elsewhere (15) . Protein purities were ϳ50% for HEL ⌬RD and 25% for HEL ⌬RDGN by SDS-PAGE. Total protein was quantitated using the bicinchoninic acid protein assay (Pierce, Rockford, IL).
Flow cytometry
Splenocytes and in vitro cultured cells were stained in FACS buffer (1ϫ PBS, 2.5% FCS, 0.1% sodium azide) with FITC-, PE-or Cy-Chromeconjugated mAbs to B220 (RA3-6B2), IgM a , IgD a , CD43, CD21, CD23, and isotype controls (all Abs from PharMingen, San Diego, CA). Threecolor flow cytometry was performed as described (10) using a FACScalibur (Becton Dickinson, Mountain View, CA) and analyzed using CellQuest (Becton Dickinson) or Flowjo (Treestar, San Carlos, CA) software.
Results
Evidence for endogenous light chain rearrangements in anergic B cells in vivo
To determine whether anergic B cells exhibit evidence for light chain editing in vivo, we prepared single-cell suspensions of spleen and BM from young (4-to 6-wk old) HEL-Ig and anergic HEL-Ig/sHEL mice, and isolated genomic DNA and total RNA. Since the HEL-Ig Tg light chain is the product of a V-J2 rearrangement (16), we used degenerate V framework primers along FIGURE 1. Endogenous V-J1 rearrangements in the BM of anergic HEL-Ig/sHEL mice. A, V-J1 and CD14 PCR were performed using genomic DNA from 40,000 splenocytes isolated from C57BL/6 (B6) mice. Samples were removed after the indicated cycle numbers, and the products were electrophoresed through 1% agarose gels, transferred to nitrocellulose, and detected by Southern blot using internal radiolabeled oligonucleotides. Data from autoradiographs were analyzed by densitometry using a Bio-Rad densitometer and software, with values plotted in the lower panel. Data are shown as relative densitometric intensity, with 100 representing the strongest signal in the titration. Data were also captured by PhosphorImager (Molecular Dynamics) analyses of the primary blots, with comparable results. Based on these data, 28 total cycles of PCR were used to detect V-J1 rearrangements and 23 total cycles were used for the CD14 control assay. B, Cell numbers were titrated in the V-J1 assay (28 cycles) and the CD14 control assay (23 cycles) over a range of 10,000 -120,000 input B6 splenocytes. After processing the samples as described above, densitometric analyses of these data indicated a linear relationship between signal intensity and the amount of input DNA (lower panel). C, Genomic DNA was isolated from the spleen (Spl) and BM of B6, HEL-Ig (Ig), and HEL-Ig/sHEL (Ig/sHEL) mice, and endogenous V-J1 rearrangements were amplified from 40,000 cell equivalents as described above with CD14 as a loading control. Negative control (lane with a primer downstream of the J1 gene segment in PCR of genomic DNA to detect endogenous V-J1 joints (10, 12) . Fig. 1 , A and B, illustrates the control experiments that were performed to validate this semiquantitative assay.
As shown in Fig. 1C , spleen and BM cells of single Tg HEL-Ig (Ig) mice showed almost no detectable endogenous V-J1 rearrangements, consistent with tight allelic exclusion by the Tg light chain. In contrast, V-J1 rearrangements were easily detected in both spleen and BM cells of anergic HEL-Ig/sHEL (Ig/sHEL) mice, with some enrichment in the spleen. In four pairs of animals examined, there was an overall 11-fold increase in the abundance of V-J1 rearrangements in the spleen of HEL-Ig/sHEL anergic mice compared with HEL-Ig mice as determined by densitometry. RT-PCR analysis demonstrated Rag-2 mRNA expression in the BM but not the spleen of HEL-Ig/sHEL mice ( Fig. 2) , suggesting that the endogenous rearrangements occurred centrally at the time when IgM receptors were first expressed on immature B cells. Rag-2 mRNA levels in the BM of HEL-Ig/sHEL mice were ϳ2-fold higher than in HEL-Ig BM (data not shown).
The total number of B220 ϩ cells in the BM of HEL-Ig and HEL-Ig/sHEL mice was comparable (3.3 Ϯ 0.2 ϫ 10 6 vs 3.3 Ϯ 0.9 ϫ 10 6 , respectively; n ϭ 3), while there were approximately twice as many B220 ϩ cells in HEL-Ig spleens compared with HEL-Ig/sHEL spleens (2.6 Ϯ 0.6 ϫ 10 7 vs 1.1 Ϯ 0.3 ϫ 10 7 , respectively; n ϭ 6). IgM b -positive, non-HEL-binding B cells (i.e., nontransgenic B cells) comprised Ͻ2% of the total cells found in either HEL-Ig or HEL-Ig/sHEL mice. Thus, the increases in V-J1 rearrangements and Rag-2 expression observed in HEL-Ig/sHEL anergic mice were not due to the presence of an expanded population of endogenous nontransgenic B cells.
In vitro HEL-Ig BM B cell cultures
We next turned to an IL-7-driven in vitro BM culture system (17) (18) (19) (20) a expression similar to that observed on HEL-Ig/sHEL splenocytes (the "a" allotype is specific for the Tg IgM receptor). In this system, the levels of IgD a were significantly lower on the cultured cells than the splenic cells of either Ig or Ig/sHEL mice, consistent with an immature phenotype (IgM ϩ , IgD neg-low ) of the majority of cultured B cells. Additional evidence for an immature phenotype of the cultured cells included the persistence of the pro-B cell marker CD43 and low surface levels of the maturation markers CD23 and CD21 (Fig. 3) . The levels of IgM a and IgD a expression correlated with HEL binding as determined by a flowcytometric HEL sandwich assay (3) (data not shown).
We noted approximately a 40% reduction in the number of viable cells recovered at day 4 in IL-7 cultures of HEL-Ig BM when incubated in the presence of HEL compared with cultures lacking the HEL Ag (Fig. 4A ). Significant reductions in DNA synthesis were also observed at the end of the first-stage culture in the presence of self-Ag (Fig. 4B) . These data were consistent with a modest Ag-mediated growth inhibition rather than Ag-induced death, since there were no consistent differences in the number of apoptotic B220 ϩ cells as determined by 7-amino-actinomycin D staining, either in the presence or absence of self-Ag (data not shown). Cells were next harvested at the end of the first-stage culture, washed, and recultured in the presence or absence of IL-4, soluble HEL, polyclonal anti-IgM Abs, or combinations of these reagents for another 2 days. In these second-stage cultures, cells incubated with HEL during the first stage showed reduced proliferation following stimulation compared with cells not exposed to Ag in the first-stage culture (Fig. 4C ). These differences were less striking than the defects observed in anergic HEL-Ig/sHEL splenic B cells analyzed in parallel (Fig. 4C) , likely due to residual IL-7 cytokine effects in the BM cells. Together, these results indicated that exposure of HEL-Ig BM cells to HEL in an IL-7-driven BM culture system leads to lowered levels of surface IgM associated with modestly reduced proliferative responses following subsequent BCR cross-linking.
In vitro receptor editing in response to BCR cross-linking by HEL self-Ag
We next tested whether HEL-Ig B cells in the BM culture system underwent endogenous light chain rearrangements in response to BCR ligation by the soluble self-Ag HEL. In first-stage IL-7 cultures, HEL-Ig B cells showed low background levels of endogenous V-J1 rearrangements in the absence of Ag (Fig. 5, lanes 4 and 6) , similar to background levels described previously in another Ig Tg system (12) . Incubation of first-stage cultures with HEL (1 g/ml) induced modest levels of new V-J1 rearrangements (lanes 5 and 7) . However, in second-stage cultures, following a wash to remove IL-7 and reculturing in the presence of HEL, there was a consistent and strong induction of endogenous V-J1 rearrangements by HEL compared with cells cultured in the absence of HEL (compare lanes 8 and 12 with  lanes 9 and 13, respectively) . Background levels of Rag-2 mRNA were quite high in this in vitro system (see also Ref. 21) , and the strong induction of new V-J rearrangements in second-stage cultures was associated with only about a 2-fold induction of Rag-2 mRNA (data not shown).
Receptor editing in response to low-affinity HEL ligands
The data shown in Figs. 1C and 5 were consistent with the hypothesis that the level of receptor cross-linking sufficient to induce FIGURE 5. Induction of receptor editing in vitro by HEL. HEL-Ig BM cells were cultured in IL-7 either with or without 1 g/ml HEL for 5 days (first stage). A portion of the cultures was harvested, washed, and then recultured in media on S17 stromal cells in the presence or absence of 1 g/ml HEL for an additional 2 days (second stage). Genomic DNA samples were isolated from first-and second-stage cultures, and levels of endogenous V-J1 rearrangements were determined as described in the legend to Fig. 1 . Ethidium-stained C locus amplifications were used as loading controls. Two representative experiments are shown. anergy in HEL-Ig B cells was also sufficient to induce editing. Thus, we next investigated the influence of lower affinity ligands for the HEL receptor on editing in the BM culture system. Two of the low-affinity ligands tested were site-directed mutants of HEL (15) (HEL ⌬RDGN ), has four alanine substitutions and a 100-fold lower affinity for the HEL-Ig receptor than HEL (15) . We also tested duck egg lysozyme (DEL) with an ϳ3500-fold reduced affinity (22) .
We first tested the influence of the various Ags to modulate HEL-specific surface IgM a levels in first-stage BM cultures. As shown in Fig. 6A , the ability of each of the ligands to down-regulate IgM a levels correlated with their affinity for the anti-HEL receptor, with HEL showing the strongest down-regulation of IgM levels and DEL the least. These results were consistent with previous studies in the HEL system, which have shown that the level of IgM a down-regulation is proportional to the strength of BCR signaling (23) .
Next, we explored the ability of the various lysozyme molecules to induce editing. HEL-Ig BM cells were incubated with IL-7 in either media alone, or with HEL, HEL ⌬RD , HEL ⌬RDGN , or DEL at 100, 500, or 2500 ng/ml for 5 days. At the end of the first-stage culture, cells were harvested for determination of V-J1 rearrangements (Fig. 6B) . Significantly, the levels of V-J1 rearrangements observed were generally proportional to the affinity and concentration of the various Ags tested. At the higher concentrations, the various soluble ligands induced stronger levels of endogenous rearrangements, and even DEL, a low-affinity ligand for the Hy-HEL10 receptor, could induce weak editing.
In second-stage cultures, the induction of editing showed less of a dose response, particularly with the higher affinity ligands HEL and HEL ⌬RD (Fig. 6C, lanes 2-7) . It appeared that cells in the second-stage cultures following withdrawal of IL-7 were somewhat "primed" to edit, compared with first-stage cultures. This was clearly observed following Ag challenge (e.g., compare lanes 2-4 of Fig. 6, B and C) , and was also seen in control cultures in the absence of Ag (lane 1 of Fig. 6, B and C) . A similar brisk induction of editing after IL-7 withdrawal was also noted in in vitro 3-83 Tg B cell cultures following BCR cross-linking (12, 20) .
Finally, we analyzed cells from each of the first-stage culture conditions shown in Fig. 6B by flow cytometry to determine the extent of IgM a down-regulation. Plotting of the mean fluorescence intensity (MFI) of IgM a levels for the various first-stage cultures against the densitometric determination of V-J1 rearrangements normalized to CD14 showed an interesting relationship between these two variables ( Fig. 6D ; each data point represents the average of three separate experiments). Cells receiving the lowest levels of BCR signaling (high IgM a MFI) showed the lowest levels of editing (Fig. 6D , bottom right portion of the graph), whereas cells receiving the strongest levels of signaling (low IgM a MFI) demonstrated the highest levels of editing (Fig. 6D, upper left portion  of the graph) . Thus, the magnitude of the editing response in this in vitro system was correlated with BCR signaling strength.
Discussion
The data presented here provide new insights into the relationship between anergy and receptor editing in maintaining central toler One conclusion from these data is that the level of BCR crosslinking sufficient to induce anergy, as classically defined in HELIg/sHEL B cells, is also sufficient to induce new endogenous light chain rearrangements. In this system, the detection of V-J1 rearrangements in HEL-Ig Tg B cells really serves only as a marker for the receptor editing response. This is because in this Tg system "genuine" light chain receptor editing, defined as editing that leads to a change in the heavy and/or light chain composition of the BCR, does not occur. The HEL-Ig animals used in these experiments are conventional Tg mice, where the heavy and light chain Tg cassettes are present at multiple copies and are cointegrated in the genome, but not at the normal endogenous heavy and light chain loci (3) . Because of this, induction of new rearrangements at the endogenous loci in HEL-Ig Tg B cells fails to remove or inactivate the autoreactive V-J gene segment, like that which occurs in normal B cells through nested V-J rearrangements (24) or RS-type recombinations (25) . Thus, receptor editing in this system can be considered a form of "frustrated" editing. The coexistence of both anergy and editing in HEL-Ig/sHEL B cells indicates that these cells are attempting to edit away from "anergic" levels of self-reactivity. Thus, anergy is one potential outcome for B cells that fail to productively edit.
Another conclusion from this work is that the level of BCR cross-linking sufficient to induce editing occurs over a broad range of BCR signaling strengths. An advantage of the lysozyme Tg system is that the level of surface IgM a expressed on HEL-Ig B cells provides a reliable readout for the level of BCR signaling strength experienced by the cells (23) . Our data indicate that the level of IgM a found on HEL-Ig/sHEL anergic splenic B cells was approximately equivalent to the IgM a levels observed on in vitro cultured BM B cells grown in the presence of 200 ng/ml HEL (Fig.  3) . We also found that editing was induced in the in vitro system after exposure to very low-affinity soluble ligands for the HEL receptor, most notably by DEL with ϳ3500-fold lower affinity than HEL. Editing in response to low-affinity ligands was previously reported in the 3-83 anti-class I MHC Tg system (26); however, because the class I molecules with low affinity for the 3-83 BCR were membrane bound and present at very high concentrations, it was difficult to estimate the true signaling strength experienced by the B cells. Taken together, these studies suggest that the BCR signaling threshold for B cell editing in immature cells may indeed be quite low. Furthermore, these findings suggest that developing B cells are likely to attempt to edit away from levels of self-reactivity that are far below the upper threshold for anergy induction.
Although receptor editing in the 3-83 anti-class I MHC Tg system was associated with increased expression of light chains in vivo (5), we have never observed elevated levels of (defined as Ͼ1% of B220 ϩ cells also positive for ) in vivo, either on anergic HEL-Ig/sHEL B cells (data not shown) or previously on anergic HEL-Ig/bcl-x L double Tg B cells escaping deletion in mHEL mice (10) . Only when HEL-Ig B cells generated in the in vitro system were incubated with very high concentrations of HEL (e.g., 50 g/ml) or received strong cross-linking from anti-IgM Abs have we observed significant staining (up to 3 or 4% of B220 ϩ cells, data not shown). Even under these extreme in vitro conditions, the cell populations did not show a detectable loss of HEL binding as determined by an HEL-specific sandwich assay (data not shown). The relative resistance of HEL-Ig Tg B cells to edit away from HEL specificity is probably explained by the fact that the HEL-Ig transgenes are conventional and randomly integrated in the genome and not subject to normal excision by deletion. In addition, it is possible that the highly somatically mutated anti-HEL heavy chain either does not pair well with endogenous or light chains, or that endogenous light chains do not compete well with the Tg chain for pairing with the Tg heavy chain.
Our finding of elevated levels of endogenous V-J1 rearrangements in anergic HEL-Ig/sHEL B cells is supported by gene-expression array analysis, which documented elevated levels of V-J5 transcripts in anergic double Tg B cells compared with naive B cells (27) . These results, however, contrast with a recent paper by Kraus et al. (28) , who found no evidence for light chain editing in anergic B cells compared with HEL-Ig B cells using a single-cell analysis. It is likely that at least two factors are contributing to this difference. The first is that Kraus et al. (28) performed their single-cell analysis on sorted BM cells, whereas we have consistently found higher levels of rearrangements in splenic B cells. Furthermore, the PCR strategy they used detected all of the potential V-J joints, including the Tg V-J2 rearrangement, using a degenerate V primer and a primer downstream of J5. In their strategy, V-J1 was the longest of the PCR products to be amplified, and it had to compete with the Tg V-J2 rearrangement. Since V-J1 is the preferred J segment for de novo rearrangements (29, 30) and the data shown by Kraus et al. (28) did not identify a single V-J1 product, we conclude that their assay may have missed the J1 rearrangements in HEL-Ig/sHEL mice that we were able to detect using a V-J1-specific strategy in unfractionated BM and spleen. Definitive resolution of this issue would likely require a single-cell PCR analysis along with Southern blot detection of V-J1 joints.
Another question that arises from these data concerns the identity of the cell population that responds to BCR cross-linking with an editing response in vitro. Specifically, is this a broad response across the population of cells, or does this represent a selective response of an activated subpopulation? Our data at present are most consistent with the notion that the editing observed represents a broad response across the population. This is supported by the proliferation data shown in Fig. 4 , where incubation with Ag resulted in lower, not higher, levels of proliferation than cultures not containing Ag. In addition, in recent experiments we have labeled cells with CFSE at the end of first-stage cultures and then followed the fate of these cells in second-stage cultures. After 2 days, there were no significant differences detected in CFSE staining between second-stage B cells cultured in the absence or presence of HEL Ag. Thus, we find no evidence for the selective outgrowth of a subpopulation in response to incubation with HEL.
The data presented here are consistent with the hypothesis that the editing response is regulated primarily by BCR signaling strength. In one respect, this is not particularly surprising, given the critical role that BCR signaling has at virtually every stage in B cell development. Currently, there are a number of important and unresolved issues regarding central receptor editing. These include the nature of the signaling pathways downstream of the BCR that regulate editing, the molecular mechanism by which editing is confined to a specific developmental stage in BM B cell development, and the mechanism by which light chain allelic exclusion is maintained during editing. The in vitro system described here, where the degree of BCR signaling and receptor editing can be modulated using soluble ligands, may prove useful in addressing some of these issues.
